Dr. Mohammad Al-Rowaily, (MSc),CRP,PhD KSA

Eeperience:
More than 18 years Comprehensive Advanced Radiopharmaceuticals, technical and educational experience with diverse administrative skills and clinical background in the field of Nuclear Medicine and PET/CT

Qualifications:
• Ph.D. In Chemical and Pharmaceutical Sciences Research Title "Targeted Radionuclide Therapy using Peptide-Based Radiopharmaceuticals" Pavia University, Pavia Italy, Feb 2017
• Fellowship in Advanced Radiopharmacy/Radiochemistry Program at European Institute of Oncology IEO Milan Italy Feb 2015-Dec 2016
• Post-Graduate Degree, Certificate of Advanced Studies (CAS), Radiopharmaceutical Chemistry/Radiopharmacy ETH, Zurich, Recognized by EANM Dec 2012.

OCT 2012 to present
KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE

• Nuclear Medicine & PET Radiopharmacy Specialist
• In charge of all Radiopharmaceuticals development within Nuclear Medicine at

KFSH & RC
• Hospital Radiation Safety Committee

Educational Activities
• SCFHS Post Graduate Exam Committee member, April 2019- December 2021
• Adjunct Assistant Professor at Alfaisal University in Radiology Master Program, March 2020
• Adjunct Assistant Professor at Princess Nora Bint Abdul Rahman University Sep 2018- present

ACOMPLISHMENTS
• Established New Theranostic Tracers at Nuclear Medicine/KFSHRC started 2013 & more than 500 cases have been done up to October 2019
• Speaker in more than 20 International Conferences
• Course Organizer for 15 courses and workshops
• Participated in establishment of a Bachelor Degree in Nuclear Medicine, Princess Nora Bint Abdul Rahman University